ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag books disease medicine biotechnology

FDA Approves Gene Therapy for Spinal Muscular Atrophy
Ashley Yeager | May 27, 2019 | 3 min read
At $2 million for a single dose, Novartis’s Zolgensma is the most expensive medicine to date, but still less expensive over a lifetime than another approved drug for the rare genetic disease.
2022 Top 10 Innovations 
2022 Top 10 Innovations
The Scientist | Dec 12, 2022 | 10+ min read
This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.
Capsule Reviews
Annie Gottlieb | Mar 1, 2013 | 3 min read
The Undead, Frankenstein's Cat, The Universe Within, and Physics in Mind
Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist | Dec 1, 2021 | 10+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
A fruit bat in the hands of a researcher
How an Early Warning Radar Could Prevent Future Pandemics
Amos Zeeberg, Undark | Feb 27, 2023 | 8 min read
Metagenomic sequencing can help detect unknown pathogens, but its widespread use faces challenges.
Gene Dreams: The Bursting Of The Biotechnology Bubble
The Scientist Staff | Apr 1, 1990 | 8 min read
[Editor's note: On Oct. 14, 1980, a small San Francisco startup firm, a company that had yet to produce a single product, cornered the imagination and captured the deep pockets of Wall Street with a dazzling new concept - biotechnology. The company, Genentech Inc., was the creation of Robert Swanson, a venture capitalist, and Herbert Boyer, a biochemist who along with a colleague had been the first to extract a gene from one organism and successfully implant it in another. Investors liked this
a newly hatched mosquito sits on top of water, with its discarded cocoon floating below
In Vitro Malaria Sporozoite Production May Lead to Cheaper Vaccines
Katherine Irving | Jan 20, 2023 | 4 min read
A method for culturing the infectious stage of the Plasmodium lifecycle could increase malaria vaccine production efficiency by tenfold, study authors say.
Flux and Uncertainty in the CRISPR Patent Landscape
Aggie Mika | Oct 1, 2017 | 10 min read
The battle for the control of the intellectual property surrounding CRISPR-Cas9 is as storied and nuanced as the technology itself.
Year in Review: CRISPR Blossoms
Jef Akst | Dec 16, 2015 | 3 min read
As researchers work to improve the precision gene-editing technology, the community discusses the best way to use it.
Following in Merck's Footsteps: Classic Scientific Books
Ricki Lewis | Mar 18, 1990 | 9 min read
Last December, the Merck Index celebrated its 100th birthday. The 2,350 pages of the latest edition, the 11th - with 10,000 entries, 8,000 structures, 62,000 synonyms, and 129 pages of charts and tables - seem a far cry from the original 170 pages published in 1889. The first edition, named for the German company (originally a pharmacy) founded in 1668, was written for the physician, chemist, and pharmacist, listing "whatever chemical products are to-day adjudged as being useful in either medi

Run a Search

ADVERTISEMENT